Zosano Pharma Corporation filed an amended disclosure statement in the US Bankruptcy Court on October 10, 2022. As per the amended statement filed, general unsecured claims are of $10.72 million with recovery expected recovery between 31% and 34%.
Zosano Pharma Corporation
Equities
ZSAN
US98979H3012
Biotechnology & Medical Research
1st Jan change | Capi. | |
---|---|---|
+15.82% | 12TCr | |
+20.35% | 11TCr | |
+17.47% | 2.6TCr | |
-25.31% | 1.94TCr | |
-19.51% | 1.59TCr | |
-19.67% | 1.51TCr | |
-46.87% | 1.51TCr | |
+62.55% | 1.49TCr | |
+6.34% | 1.39TCr |